Beta-blockers curb death risk in high-risk STEMI patients

02/17/2013 | PhysiciansBriefing.com

A study in The American Journal of Cardiology found beta-blocker treatment may help cut long-term mortality in high-risk ST-segment elevation myocardial infarction patients. However, the therapy did not appear to benefit lower-risk patients, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT